STOCKS TELEGRAPH

Author: Shariq Khan

  • Exela Technologies, Inc. (XELA) surged in the current market; here is why?

    Exela Technologies, Inc. (XELA) surged in the current market; here is why?

    Exela Technologies, Inc. (XELA) gained in the current market after the company announced an increase in Exchange Offer Consideration for Common Stock to $1.25 of New Notes per Share. XELA values at $0.86 in the current market, gaining more than 6.82% compared to yesterday’s closed price. The stock closed at around $0.81 at the end of the previous trading session with a trading volume of approximately 51.62 million shares.

    Exela Technologies, Inc. (XELA) increased in Exchange Offer

    Exela Technologies, Inc. (XELA) is a multinational BPM company. SourceHOV LCC, Novitex Holdings, Inc., and Quinpario Acquisition Corp. merged to form it.

    Exela Technologies, Inc. (XELA) announced in a press release today that it has revised its previously announced offer to swap up to 100,000,000 shares of its Common Stock for unsecured 6.00 percent senior notes due 2029. Since each share of Common Stock is now worth $1.25 instead of $1.00, the total value offered per share is now $1.25 as well.

    The exchange of Common Stock for New Notes is now available in 20-share increments for $25 in New Notes for shareholders. On January 25, 2022, the stock closed at $0.55, representing a 127 percent premium. There will be a 30 percent reduction in the total number of shares when the tenders are accepted. Due to the increased price for the exchange, only 20-share lots of Common Stock may be offered and up to $125,000,000 in New Notes may be given.

    Exela Technologies, Inc. (XELA) lost around 70% in the last 12 months

    Price records contain a stock’s low and high price history over a 52-week period. In the last 52 weeks, Exela Technologies Inc. shares have fallen by 70 percent, yet it has risen by 130 percent from their lowest price point of $0.35. There was no significant change in the stock’s 52-week price range, which remained between $0.35 and $7.82.

    Exela Technologies, Inc. (XELA) shares reached a trading volume of over 51.62 million yesterday, much greater than the shares’ usual daily volumes. If we look at Exela Technologies YTD’s metrics, we see that the company has performed in the has declined market 1.38%, with revenues showing an annual decrease of 59.72%. The market cap of Exela Technologies is $159.59 million right now.

    Conclusion

    Exela Technologies, Inc. (XELA) has lost significant value in the trailing twelve months. The current exchange offer shows that the company is keen on increasing the stock value. They also have to meet the NASDAQ’s compliance of keeping the stock value above $1 per share.

  • Spirit Airlines, Inc. (SAVE) is gaining in the pre-market, here is why?

    Spirit Airlines, Inc. (SAVE) skyrocketed in the pre-market after announcing fourth quarter and fiscal 2021 results and merger with Frontier in two consecutive press releases. SAVE values at $24.46 in the pre-market, gaining more than 12% from yesterday’s closing price. The stock closed at $21.73 at the end of the last trading session. The stock volume traded in the previous trading session was around 5.19 million shares.

    Spirit Airlines, Inc. (SAVE) merger with Frontier Airlines

    On February 7, 2022, Spirit Airlines, Inc. (SAVE) and Frontier Airlines announced in a press release today that both the companies were merging. As a result of the merger of Frontier Airlines with Spirit Airlines, America’s most competitive ultra-low-fare airline will establish. The two highly complementary networks will service over 145 destinations throughout the United States, Latin America, and the Caribbean. Even more low-cost flights to a more significant number of destinations: A $1 billion annual savings for consumers is anticipated.

    Small and medium-sized urban regions in the United States benefit from airline consolidation as more competition and service are provided to them. According to the company, this fleet will be the most modern, most energy-efficient, and most environmentally friendly in the entire United States. The combination provides better opportunities and more excellent stability for 15,000 professionals, resulting in 10,000 direct jobs by 2026.

    Fourth-quarter 2021 highlights

    The company’s revenue was $987.6 million, and its net loss was around $87.2 million. SAVE reported diluted earnings (loss) per share of $0.80. The financial numbers improved in the third quarter compared to the fourth quarter of 2020. The revenue has almost doubled in value, and the net loss has been enhanced by more than 220%.

    The impact of Covid-19 and the new variants on SAVE business

    The impact of the COVID-19 pandemic has changed and evolved since its inception in early 2020. Thus, the Company’s financial and operational outlook is fluid. They continue to evaluate the pandemic’s impact on their operations and finances and change their mitigation and operating plans accordingly. The company has taken steps to ensure the safety of its customers and staff and its financial and operational health. It is owing to the devastating impact of the COVID-19 pandemic on their financial and operational outcomes for 2020.

  • Hut 8 Mining Corp. (HUT) stock is gaining in the Pre-market; here is why?

    Hut 8 Mining Corp. (HUT) is amongst the most prominent digital currency miners globally. They specialize in the mining of Bitcoin and Ethereum.

    Hut 8 Mining Corp. (HUT) surged in the pre-market as soon as the company announced monthly production and operations Updates for January 2022. Its stock values are at $8.26, gaining more than 13% from yesterday. HUT closed at $7.31 at the end of the previous trading session. The stock volume was around 2.59 million shares in the last trading session.

    January 2022 Mining Production Highlights:

    • As a result, a daily production rate of 9.93 bitcoins was achieved by mining 308 bitcoins.
    • In line with Hut 8’s Hodl strategy, all of January’s self-mined Bitcoins were placed in safekeeping.
    • As of January 31, 2022, the total amount of Bitcoin in reserve was 5,826.
    • At 2.36 EH/s, installed operating capacity has grown by 17% since December 31, 2021.

    The following are the January 2022 operational updates:

    • Bitfury Clarkes were retired in January 2022 and installed 6,317 MicroBT M30S and M31S+ miners.
    • Additionally, the construction and development of Hut 8’s third data center in North Bay, Ontario, has progressed significantly. The structure is finished, floors will be poured soon, and racking will begin in the second half of February 2022.

    Head of Technology for Hut 8 Remarks about the monthly achievements

    Jason Zaluski, Hut 8’s head of technology, stated that his team is working hard to deploy extra miners between our two Alberta-based locations, enhancing overall efficiency and hash rate leveraging current capacity. Our team in Alberta has been receiving and ultimately deploying our MicroBT units as quickly as feasible, which demonstrates their dedication and ability to use the most efficient miners possible.

    HUT: Key Financials

    The company’s current market cap is CAD 1.41 billion. Hut 8 Mining Corp. (HUT) revenue in the third quarter was CAD 50.34 million. It’s a gain of 774% from the 3rd quarter of 2020. The basic and diluted EPS was CAD 0.15, gaining 1600% from the third quarter of 2020. The net income was around CAD 23.37 million, reporting an increase of 2600% compared to the same period in 2020.

    Conclusion

    HUT is currently a hot stock with outstanding performance. The company is yet to announce its results for the fourth quarter and fiscal 2021. Its stock may increase as soon as it closes its books for fiscal 2021.

  • Redwire Corporation (RDW) stock gained in the current market; here is why?

    Redwire Corporation (RDW) stock gained in the current market after the company announced its preliminary financial results for the year ending December 31, 2021, and provided an update on Q3 2021 10-Q filing. RDW values at around $5.81 in the current market, gaining more than 9.83% from the previously closed value. The stock of RDW closed at $5.28 at the end of the previous trading session. The stock volume traded in the last trading session was around 0.506 million shares.

    Highlights of the RDW preliminary revenue results

    Redwire Corporation (RDW) today reported preliminary financial results for the year ending December 31, 2021, and provided an update on the status of its Form 10-Q for the quarter ended September 30, 2021.

    On average, Redwire expects to earn between $135 and $140 million in GAAP revenue and $146 and $151 million in pro forma revenue in 2021.

    The results show a year-on-year sales rise of almost 160 percent GAAP and 30 percent pro forma. Our contracted backlog is estimated to be between $133 million and $138 million by December 31, 2021, and our uncontracted backlog anticipates between $136 million and $138 million.

    CEO is excited by the recent growth

    The CEO of RDW said that they are proud of our business achievements in 2021. Meanwhile, they’re spending heavily on new technology that will impact the future of space for centuries to come. This distinctive heritage plus innovation strategy recorded significant revenue growth due to this remarkable heritage plus innovation strategy.

    He further added that the Board of Directors and the Redwire team take accuracy and compliance extremely seriously. He said that they look forward to positioning Redwire for long-term success. Their plans for human expansion into space go beyond the next decade.

    Impact on the stock

    Redwire Corporation (RDW) gained in the current market following its preliminary revenue results became public. Investors are investing in its stock. Many institutional investors expect its future growth and have rated it a buy on its current price range. Analysts agree that investors should “buy” Redwire shares. They expect Redwire’s stock will hit $15.00 in the next year. It implies a 146.7 percent potential gain from the current price. Many retail and institutional investors own Redwire stock. Cutler Group LP and J.W. Cole Advisors Inc. are amongst the top investors.

  • Lightning eMotors, Inc. (ZEV) stock gained in the current market; here is why?

    Lightning eMotors, Inc. (ZEV) stock gained in the current market after the company announced a deal with General Motors. ZEV values at around $5.00, gaining more than 15.07% from the previously closed value. The stock of ZEV closed at $4.35 at the end of the previous trading session. The stock volume traded in the last trading session was around $1.09 million shares.

    Lightning eMotors, Inc. (ZEV) agreement with General Motors

    Lightning eMotors, Inc. (ZEV) announced in a news release that they had struck a deal with General Motors. With this deal, they became the first GM Specialty Vehicle Manufacturer (SVM) to produce electric Class 3 through Class 6 commercial vehicles.

    Numerous vehicle applications can benefit from this arrangement, including buses, delivery trucks, work trucks, and more. Lightning eMotors will electrify General Motors’ famous medium-duty truck platforms.

    For eligible Specialty Vehicle Manufacturing customers, General Motors Fleet offers a choice of platforms for the up-fitting of vehicles across a wide range of industries and applications.

    CEO statement about the deal

    According to its CEO, electric trucks based on GM’s medium-duty truck chassis will be the focus of the company’s next round of development. Lightning’s position and status as a top powertrain supplier in the commercial vehicle sector are perfect for GM’s inclusive approach to electrification. For commercial cars and commercial vehicle powertrains that require years of custom software and on-the-road testing, Lightning has products in fleet usage and is available for customers to implement this year.

    The interest of institutional investors in ZEV stock

    Morgan Stanley increased its investment in Lightning eMotors by 17.8% in Q3. Morgan Stanley now owns 66,164 shares of the company’s stock worth $566,000. It is an increase of 9,982 shares from last quarter. Other institutional investors have lately increased or decreased their stakes in the company. Hedge funds and different institutional investors hold 6.62% of the company’s stock. Advisor Group Holdings Inc. invested $29,000 in ZEV. Wells Fargo & Company MN and Penserra Capital Management LLC bought around $68,000 worth of stock.

    Conclusion

    Currently, the ZEV stock is rated as Hold, and analysts expect it to incline in the upcoming months. The stock might be overvalued now, and investors should wait for a dip to purchase its stock.

  • Biophytis SA (BPTS) stock surged in the Pre-market; here is why?

    Biophys SA (BPTS) stock gained in the pre-market after announcing that ANVISA has approved its Covid-19 treatment. BPTS values at $5.28, gaining more than 13.5% from yesterday’s closed value. The stock closed at $4.65 at the end of the previous trading session. The stock volume traded in the previous trading session was around 2.6K shares.

    Biophys SA (BPTS) Covid-19 treatment approval by ANVISA

    Biophys SA (BPTS) today announced that ANVISA had approved its Expanded Access Program (EAP) for treating hospitalized COVID-19 patients with Sarconeos (BIO101). Sarcone’s (BIO101) is prescribed to 80 ventilated patients in Brazilian hospitals for up to 28 days.

    EAP’s acceptance by ANVISA is based on these factors:

    • Patients with disabling or life-threatening diseases are the target audience.
    • No satisfactory therapeutic alternative using Brazilian products.
    • The authorization of the product is only provided by prescribing practitioner.

    CEO’s remark about the recent development

    The CEO of Biophytis SA (BPTS) said that our next step is to make Sarconeos (BIO101) available to critically ill ICU patients with severe Covid-19. This initiative will yield fresh data on the safety of Sarconeos (BIO101) and its potential efficacy in mechanically ventilated patients and unique indications.

    Analysts ratings about Biophytis SA (BPTS)

    CNN Business states that Biophytis SA is currently growing and is expected to hit the median target price of $15 per share. Currently, BPTS trades for around $4.65. The median price represents an increase of around 230%.

    Analysts have a mutual consensus about BPTS on Buy rating. They have ranked BPTS a Buy since December 2021 and since then, the rating has not changed.

    Conclusion

    The approval of the company’s Covid-19 treatment by ANVISA is a major breakthrough in its business. This will prove to be a significant revenue stream and make the company profitable.

  • Redbox Entertainment Inc. (RDBX) plunged in the current market; here is why?

    Redbox Entertainment Inc. (RDBX) declined in the current market after announcing a press release about its sec filing. RDBX stock plummeted over -48% intraday to trade at $2.75 a share on NASDAQ. The stock closed at $5.33 at the end of the previous trading session. The stock volume traded in the last trading session was around 224.16K shares.

    Redbox Entertainment Inc. (RDBX) SEC Filing

    RDBX plunged in the current market after the company announced sec filing. Redbox Entertainment Inc. (RDBX) liquidates 6.0625 million common stock shares at a par value of $0.00001 per share. It will be issuable upon the exercise of private placement warrants. Up to 10.781 million shares of Class A common stock and up to 32 million shares of Class A common stock underlying an equal number of Class B common stock shares at a par value of $0.0001 per share. 

    Their common stock is listed under the ticker symbol on NASDAQ at RDBX and warrants at RDBXW.

    What do analysts have to say about RDBX stock?

    Analysts at WSJ and Zacks anticipate that investors should keep the stock on hold at the moment, and you can also buy its shares at its decline for future capital gain. They expect the stock to reach the highest value of a maximum of $35 per share. On Average, it will be around $21, and the lowest price could be $15 per share. The median price of the share is will be $17.

    The analysts expect RDBX to announce an EPS of $3.28 for fiscal 2022. They expect the EPS to range between $3.09 and $3.46.

    Many analysts have changed their rating from sell to buy, including Zacks Investment research, WSJ, UBS Group, and Wedbush.

    What next?

    RDBX’s stock is highly volatile right now, and it is preferred by the top industry analyst to keep it on hold if you have any of its stock. But if you are planning to buy its stock, it is the one in a million-time opportunity to buy as they are betting a massive increase in the future. Currently, it is trading for $2.75, and the minimum it will reach is $15 per share, and the maximum it can go is $35 per share. 

  • Capri Holdings Limited (CPRI) stock gained in the Current Market; here is why?

    Capri Holdings Limited (CPRI) stock gained in the current market after the company announced its results for the third quarter of 2022. CPRI values at around $65.87 in the current market, gaining more than 7.14% from the previously closed value. The stock closed at $61.49 at the end of the last trading session. The stock traded in the previous trading session was approximately 1.53 million shares.

    Highlights of third-quarter results

    • Capri Holdings Limited (CPRI) reported revenue of around $1.6 billion in the third quarter of fiscal 2022. It gains more than 24% from the third quarter of 2021.
    • Their gross profit in the 3rd quarter was around $1 billion, while their gross margin was 65.1%.
    • The operating income of CPRI in the 3rd quarter was $331 million, with an operating margin of 20.6 percent. Last year in the same quarter, the operating income was $167 million and 12.8%.
    • Compared to the prior year, adjusted income from operations was $359 million, and operating margin was 22.3 percent, up from $257 million and 19.7 percent.
    • Comparatively, net income for the preceding year was $179 million, or $1.18 per diluted share, while net income for the current year was $322 million, or $2.11 per share.
    • Compared to the prior year’s adjusted net income of $250 million, or $1.65 per diluted share, the current year’s adjusted net income was $339 million, or $2.22 per diluted share.

    The effect on CPRI stock

    CPRI is gaining in the market following its release of financial results in the press release today. Investors are responding positively to the stock and investing heavily in CPRI. Most of the investors prefer to trade in the regular trading session. That is why its stock is roaring in the current market.

    Conclusion

    The outlook of the company for 2022 seems promising. Capri Holdings Limited (CPRI) expects to increase its revenue across all its brands. It is expecting revenue of $5.56 in 2022.

  • Arbutus Biopharma Corporation (ABUS) stock surged in the Pre-market; here is why?

    The stock of ABUS gained significantly in the pre-market after the company was upgraded from hold to buy by the analyst firm Jefferies. ABUS values at $3.10, gaining more than 6.16% from the previously closed value. The stock closed at $2.92 at the end of the last trading session. The stock volume traded in the previous trading session was around 3.48 million shares.

    ABUS upgraded from hold to buy by Jefferies

    Arbutus Biopharma Corporation’s (ABUS) shares have been upgraded from a hold to a buy by the analyst firm Jefferies. As of February 1, 2022, the business anticipates that the stock of Arbutus Biopharma Corporation (ABUS) will have increased by about 71 percent from its previous closing price. On February 1, 2022, the stock reached a high of $2.92.

    The stock analysts at Jefferies anticipate that the price of ABUS stock will rise from $2.92 to between $4 and $5 per common stock share, up from its current price of $2.92.

    The company has just provided its corporate and financial objectives and their financial results on January 24, 2022. Arbutus Biopharma Corporation (ABUS) has released a list of anticipated critical milestones, with the first of these expected in the second half of 2022.

    The effect on the ABUS stock

    Arbutus Biopharma Corporation (ABUS) was hot in the pre-market trading session. Investors are responding positively to the buy status by Jefferies. When the regular trading session starts, the stock is expected to increase as the pre-market hours become more volatile. Investors prefer to trade in the regular trading session. That is why the stock may surge more than the current value in the pre-market.

    Conclusion

    ABUS is going upward as soon as the news hits the market. The company is expecting some positive results in 2022. Arbutus Biopharma expects a significant gain in the financial number, due to which the analyst has ranked it a strong buy with a 71% increase in the value.

  • MVST stock: Microvast Holdings gained in the Pre-market; here is why?

    Microvast Holdings, Inc. (MVST) stock gained in the pre-market after the company announced the revenue guidance for fiscal 2021. MVST values at $6.51, gaining more than 6% from the previously closed value. Microvast Holdings, Inc. (MVST) stock closed at $6.13 at the end of the previously closed session. The stock volume traded in the last trading session was around 1.18 million shares.

    MVST revenue guidance 2021

    It has been confirmed today by Microvast Holdings, Inc. (MVST) that its sales performance for the fiscal year ending December 31, 2021, would be within the earlier disclosed guidance of $145-$155 million. It marks a 42 percent increase over the previous fiscal year, which ended on December 30, 2020, at $108 million.

    They are thrilled to end out 2021 with an outstanding sales achievement in the fourth quarter and a solid backlog going into 2022. Amid the backdrop of a challenging year, they are encouraged by their accomplishments and their ability to expand top-line sales. They are looking forward to building on this great energy into 2022 as they embark on our electrification mission together.

    Immediately following the close of the market on Tuesday, March 29, 2022, the Company will release a press release announcing its combined financial results for the fourth quarter and full fiscal year ended December 31, 2021.

    The effect on the MVST stock

    MVST announced some positive performance for the fiscal year 2021. Investors responded positively to the news due to the significant increase in revenue. The revenue has gained significantly as compared to fiscal 2021. The stock is doing well in the volatile trading session as most traders prefer to trade in the regular trading session.

    Conclusion

    Microvast Holdings, Inc. (MVST) will announce its results for the fourth quarter and fiscal 2021 in March 2022. Its stock may go upward due to its excellent performance in fiscal 2021.